Literature DB >> 11390412

COX in a crystal ball: current status and future promise of prostaglandin research.

G A FitzGerald1, P Loll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11390412      PMCID： PMC209326          DOI： 10.1172/JCI13037

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  14 in total

1.  Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors.

Authors:  A S Kalgutkar; B C Crews; S W Rowlinson; A B Marnett; K R Kozak; R P Remmel; L J Marnett
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  Prostaglandins, aspirin-like drugs and the oedema of inflammation.

Authors:  S Moncada; S H Ferreira; J R Vane
Journal:  Nature       Date:  1973-11-23       Impact factor: 49.962

3.  Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.

Authors:  R G Kurumbail; A M Stevens; J K Gierse; J J McDonald; R A Stegeman; J Y Pak; D Gildehaus; J M Miyashiro; T D Penning; K Seibert; P C Isakson; W C Stallings
Journal:  Nature       Date:  1996 Dec 19-26       Impact factor: 49.962

4.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.

Authors:  F E Silverstein; G Faich; J L Goldstein; L S Simon; T Pincus; A Whelton; R Makuch; G Eisen; N M Agrawal; W F Stenson; A M Burr; W W Zhao; J D Kent; J B Lefkowith; K M Verburg; G S Geis
Journal:  JAMA       Date:  2000-09-13       Impact factor: 56.272

5.  Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene.

Authors:  D A Kujubu; H R Herschman
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

6.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

Authors:  C Bombardier; L Laine; A Reicin; D Shapiro; R Burgos-Vargas; B Davis; R Day; M B Ferraz; C J Hawkey; M C Hochberg; T K Kvien; T J Schnitzer
Journal:  N Engl J Med       Date:  2000-11-23       Impact factor: 91.245

7.  Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

Authors:  W L Xie; J G Chipman; D L Robertson; R L Erikson; D L Simmons
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Acetylation of prostaglandin synthase by aspirin.

Authors:  G J Roth; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

9.  The release of prostaglandins and rabbit aorta contracting substance (RCS) from rabbit spleen and its antagonism by anti-inflammatory drugs.

Authors:  R Gryglewski; J R Vane
Journal:  Br J Pharmacol       Date:  1972-05       Impact factor: 8.739

10.  Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence.

Authors:  D L DeWitt; W L Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205
View more
  9 in total

1.  The expanding network of redox signaling: new observations, complexities, and perspectives.

Authors:  Roy J Soberman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

Review 2.  PPARgamma as a new therapeutic target in inflammatory bowel diseases.

Authors:  L Dubuquoy; C Rousseaux; X Thuru; L Peyrin-Biroulet; O Romano; P Chavatte; M Chamaillard; P Desreumaux
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

Review 3.  Do some inhibitors of COX-2 increase the risk of thromboembolic events?: Linking pharmacology with pharmacoepidemiology.

Authors:  David W J Clark; Deborah Layton; Saad A W Shakir
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Prostanoids in health and disease.

Authors:  Emer M Smyth; Tilo Grosser; Miao Wang; Ying Yu; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2008-12-17       Impact factor: 5.922

5.  Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility.

Authors:  Laura E Fredenburgh; Jun Ma; Mark A Perrella
Journal:  Trends Cardiovasc Med       Date:  2009-02       Impact factor: 6.677

6.  PG F(2α) Receptor: A Promising Therapeutic Target for Cardiovascular Disease.

Authors:  Jian Zhang; Yanjun Gong; Ying Yu
Journal:  Front Pharmacol       Date:  2010-10-14       Impact factor: 5.810

7.  Comparison of pharmacological and genetic inhibition of cyclooxygenase-2: effects on adult neurogenesis in the hippocampal dentate gyrus.

Authors:  Sung Min Nam; Jong Whi Kim; Dae Young Yoo; Jung Hoon Choi; Woosuk Kim; Hyo Young Jung; Moo-Ho Won; In Koo Hwang; Je Kyung Seong; Yeo Sung Yoon
Journal:  J Vet Sci       Date:  2014-12-24       Impact factor: 1.672

Review 8.  The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis.

Authors:  Wei Liu; Lei Zhang; Hui-Jing Xu; Yan Li; Chuan-Min Hu; Jing-Yan Yang; Mei-Yan Sun
Journal:  Int J Mol Sci       Date:  2018-09-13       Impact factor: 5.923

Review 9.  Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2.

Authors:  Ioannis A Voutsadakis
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.